Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease

NCT06978439 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Kawasaki Disease
Pilot Study
Coronary Artery Aneurysm
Rivaroxaban

Interventions

DRUG: Rivaroxaban (Xarelto)

Sponsor

Children's Hospital of Fudan University